Qube Research & Technologies (QRT)’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
RCM
SIA
KIM
AC
Qube Research & Technologies (QRT)'s ECAT Position: Q2 2024 in Review
Qube Research & Technologies (QRT) sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q2 2024, closing a stake of 122,155 shares — an estimated $2.12M sold.
Qube Research & Technologies (QRT) first reported a position in ECAT in Q4 2022 and held it in 6 quarters. The position peaked at $2.12M in Q1 2024. 63 funds tracked by Wall St. Rank hold ECAT as of Q2 2024.
- Qube Research & Technologies (QRT) reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q2 2024 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 122,155 BlackRock ESG Capital Allocation Term Trust shares in Q2 2024, an estimated $2.12M.
- Qube Research & Technologies (QRT) first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2022 and held it in 6 quarters.
- Qube Research & Technologies (QRT)'s BlackRock ESG Capital Allocation Term Trust position peaked at $2.12M in Q1 2024.
- 63 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2024.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.